دورية أكاديمية
أعرض في EDS

Risk-predicted dual nomograms consisting of clinical and ultrasound factors for downgrading BI-RADS category 4a breast lesions - A multiple centre study.

التفاصيل البيبلوغرافية
العنوان: Risk-predicted dual nomograms consisting of clinical and ultrasound factors for downgrading BI-RADS category 4a breast lesions - A multiple centre study.
المؤلفون: Niu Z; Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China., Tian JW; Department of Ultrasound, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China., Ran HT; Department of Ultrasound, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China; Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing 400010, China., Ren WD; Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang 110004, China., Chang C; Department of Medical Ultrasound, Fudan University Shanghai Cancer Center & Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Yuan JJ; Department of Ultrasonography, Henan Provincial People's Hospital, Zhengzhou 450003, China., Kang CS; Department of Ultrasound, Shanxi Academy of Medical Science, Dayi Hospital of Shanxi Medical University, Taiyuan 030032, China., Deng YB; Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China., Wang H; Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun 130033, China., Luo BM; Department of Ultrasound, the Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China., Guo SL; Department of Ultrasonography, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China., Zhou Q; Department of Medical Ultrasound, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710004, China., Xue ES; Department of Ultrasound, Union Hospital of Fujian Medical University, Fujian Institute of Ultrasound Medicine, Fuzhou 350001, China., Zhan WW; Department of Ultrasound, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, China., Zhou Q; Department of Ultrasonography, Renmin Hospital of Wuhan University, Wuhan 430060, China., Li J; Department of Ultrasound, Qilu Hospital, Shandong University, Jinan 250012, China., Zhou P; Department of Ultrasound, the Third Xiangya Hospital of Central South University, Changsha 410013, China., Zhang CQ; Department of Ultrasound, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Chen M; Department of Ultrasound Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China., Gu Y; Department of Ultrasonography, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China., Xu JF; Department of Ultrasound, Shenzhen People's Hospital, the Second Clinical Medical College of Jinan University, Shenzhen 518020, China., Chen W; Department of Ultrasound, the First Hospital of Shanxi Medical University, Taiyuan 030001, China., Zhang YH; Department of Ultrasound, the Second Hospital of Dalian Medical University, Dalian 116027, China., Wang HQ; Department of Ultrasound, the Affiliated Hospital of Qingdao University, Qingdao 266003, China., Li JC; Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China., Wang HY; Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China., Jiang YX; Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
المصدر: Journal of Cancer [J Cancer] 2021 Jan 01; Vol. 12 (1), pp. 292-304. Date of Electronic Publication: 2021 Jan 01 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Wyoming, N.S.W. : Ivyspring International Publisher, 2010-
مستخلص: Purpose: To develop and to validate a risk-predicted nomogram for downgrading Breast Imaging Reporting and Data System (BI-RADS) category 4a breast lesions. Patients and Methods: We enrolled 680 patients with breast lesions that were diagnosed as BI-RADS category 4a by conventional ultrasound from December 2018 to June 2019. All 4a lesions were randomly divided into development and validation groups at the ratio of 3:1. In the development group consisting of 499 cases, the multiple clinical and ultrasound predicted factors were extracted, and dual-predicted nomograms were constructed by multivariable logistic regression analysis, named clinical nomogram and ultrasound nomogram, respectively. Patients were twice classified as either "high risk" or "low risk" in the two nomograms. The performance of these dual nomograms was assessed by an independent validation group of 181 cases. Receiver Operating Characteristic (ROC) curve and diagnostic value were calculated to evaluate the applicability of the new model. Results: After multiple logistic regression analysis, the clinical nomogram included 2 predictors: age and the first-degree family members with breast cancer. The area under the curve (AUC) value for the clinical nomogram was 0.661 and 0.712 for the development and validation groups, respectively. The ultrasound nomogram included 3 independent predictors (margins, calcification and strain ratio), and the AUC value in this nomogram was 0.782 and 0.747 in the development and validation groups, respectively. In the development group of 499 patients, approximately 50.90% (254/499) of patients were twice classified "low risk", with a malignancy rate of 1.18%. In the validation group of 181 patients, approximately 47.51% (86/181) of patients had been twice classified as "low risk", with a malignancy rate of 1.16%. Conclusions: A dual-predicted nomogram incorporating clinical factors and imaging characteristics is an applicable model for downgrading the low-risk lesions in BI-RADS category 4a and shows good stability and accuracy, which is useful for decreasing the rate of invasive examinations and surgery.
Competing Interests: Competing Interests: The authors have declared that no competing interest exists.
(© The author(s).)
References: BMC Cancer. 2012 Nov 19;12:529. (PMID: 23164155)
Breast Cancer Res Treat. 1988 Jul;11(3):263-7. (PMID: 3167232)
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):310-320. (PMID: 29684522)
Ultrasound Med Biol. 1990;16(6):553-9. (PMID: 2238263)
Breast Cancer Res Treat. 2017 Jul;164(2):263-284. (PMID: 28444533)
Asian Pac J Cancer Prev. 2019 Aug 01;20(8):2385-2389. (PMID: 31450910)
AJR Am J Roentgenol. 2008 May;190(5):1209-15. (PMID: 18430833)
Breast Cancer Res Treat. 2017 Aug;165(1):193-200. (PMID: 28578505)
Br J Cancer. 2008 Apr 22;98(8):1457-66. (PMID: 18349832)
Breast Cancer Res. 2014 Sep 28;16(5):446. (PMID: 25467785)
J Clin Oncol. 2016 Mar 9;34(16):1840-1843. (PMID: 26962096)
Ultrasound Med Biol. 2014 Oct;40(10):2336-44. (PMID: 25130444)
Acta Radiol. 2019 Mar;60(3):278-285. (PMID: 29890844)
Breast Cancer Res. 2007;9(5):213. (PMID: 17888188)
Breast Cancer Res Treat. 2012 Aug;134(3):923-31. (PMID: 22418703)
Radiology. 2006 May;239(2):341-50. (PMID: 16484352)
J Ultrasound Med. 2018 Jan;37(1):99-109. (PMID: 28688156)
Heliyon. 2020 Apr 22;6(4):e03794. (PMID: 32346636)
AJR Am J Roentgenol. 2019 Dec;213(6):1397-1402. (PMID: 31553658)
Ultrasound Med Biol. 2019 Sep;45(9):2317-2327. (PMID: 31221510)
Cancer Med. 2019 Apr;8(4):1882-1892. (PMID: 30761775)
Radiology. 2017 Nov;285(2):660-669. (PMID: 28640693)
Ultraschall Med. 2011 Aug;32(4):400-5. (PMID: 20425688)
Med Sci Monit. 2018 Aug 09;24:5528-5532. (PMID: 30089770)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
J Natl Cancer Inst. 2020 May 1;112(5):489-497. (PMID: 31556450)
فهرسة مساهمة: Keywords: Breast cancer; Nomogram; elastography; risk factors; ultrasonography
تواريخ الأحداث: Date Created: 20210104 Latest Revision: 20210105
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC7738830
DOI: 10.7150/jca.51302
PMID: 33391426
قاعدة البيانات: MEDLINE
الوصف
تدمد:1837-9664
DOI:10.7150/jca.51302